Hospital
Tombigbee Healthcare Authority
Tombigbee Healthcare Authority was paid $1.50M by Medicaid between Jan 2018 and Nov 2024, across 102 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 54% of everything it billed.
33Billing provider infoTOMBIGBEE HEALTHCARE AUTHORITY
DEMOPOLIS, AL 36732
DEMOPOLIS, AL 36732
33aNPI1588690085assigned 06/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.50M
24GClaims90,530
24DCodes billed102
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#34 of 77
Median peer was paid$1.13M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,949 | $201K | |
| 2019 | 16,292 | $190K | |
| 2020 | 8,832 | $116K | |
| 2021 | 8,257 | $172K | |
| 2022 | 12,396 | $274K | |
| 2023 | 13,609 | $323K | |
| 2024incomplete | 13,195 | $227K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 54% | 24,410 | 21,542 | $819K |
| 87631 | 8.0% | 2,080 | 1,885 | $121K | |
| 80053 | Comprehensive metabolic panel | 4.7% | 8,466 | 6,999 | $71K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.1% | 8,916 | 7,537 | $62K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 3.4% | 568 | 241 | $52K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.4% | 2,837 | 2,057 | $51K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.9% | 1,855 | 1,553 | $43K |
| 87430 | 1.8% | 2,003 | 1,840 | $28K | |
| 87070 | 1.7% | 2,819 | 2,546 | $26K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 575 | 517 | $21K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 1,079 | 967 | $19K |
| 80061 | Lipid panel | 1.2% | 1,159 | 1,011 | $18K |
90 more codes
| 99284 | Emergency room visit (serious) | 1.1% | 541 | $16K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,184 | $14K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 168 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,825 | $11K |
| 99283 | Emergency room visit (moderate) | <1% | 960 | $11K |
| 81001 | <1% | 3,551 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,377 | $9K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 278 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 836 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 147 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,136 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,480 | $6K |
| 87254 | <1% | 568 | $5K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 19 | $4K |
| 86756 | <1% | 206 | $4K | |
| 99285 | Emergency room visit (most serious) | <1% | 18 | $3K |
| 86701 | <1% | 207 | $3K | |
| 80076 | <1% | 356 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 92 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 220 | $2K |
| 86592 | <1% | 300 | $2K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 13 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,186 | $1K |
| 96367 | <1% | 63 | $1K | |
| 86850 | <1% | 204 | $1K | |
| 83690 | <1% | 286 | $1K | |
| 86762 | <1% | 58 | $1K | |
| 85027 | <1% | 762 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 107 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,944 | $1K |
| 84484 | <1% | 193 | $1K | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 39 | $1K |
| 87340 | <1% | 57 | $897.97 | |
| 87077 | <1% | 129 | $889.02 | |
| 85007 | <1% | 175 | $735.15 | |
| 82550 | <1% | 162 | $672.00 | |
| 82150 | <1% | 150 | $621.39 | |
| 87186 | <1% | 95 | $576.27 | |
| 81025 | <1% | 164 | $555.37 | |
| 85018 | <1% | 173 | $534.94 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 592 | $504.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 47 | $450.30 |
| 83655 | <1% | 27 | $437.32 | |
| 85014 | <1% | 137 | $415.76 | |
| 84439 | <1% | 39 | $390.71 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 142 | $332.50 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 280 | $323.00 |
| 85660 | <1% | 54 | $304.41 | |
| 82950 | <1% | 43 | $247.45 | |
| 83735 | <1% | 26 | $246.16 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 181 | $243.16 |
| 86900 | <1% | 71 | $233.52 | |
| 86901 | <1% | 71 | $231.38 | |
| 0011A | <1% | 13 | $215.52 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 140 | $141.66 |
| 74018 | <1% | 15 | $136.08 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 18 | $134.80 |
| 80305 | <1% | 15 | $115.17 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 26 | $106.36 |
| 82728 | <1% | 18 | $89.68 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 96 | $87.85 |
| 83550 | <1% | 13 | $82.39 | |
| 87210 | <1% | 15 | $82.24 | |
| 86593 | <1% | 17 | $80.80 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 271 | $78.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 357 | $69.75 |
| 83605 | <1% | 14 | $67.26 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 13 | $54.16 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 28 | $52.58 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 141 | $24.27 |
| J2704 | Injection, propofol, 10 mg | <1% | 731 | $23.41 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 96 | $13.00 |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,630 | $11.12 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 52 | $7.93 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 12 | $1.04 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 17 | $0.89 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 71 | $0.36 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 192 | $0.00 |
| 3078F | 0% | 91 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 29 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 25 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 15 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 14 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 143 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 88 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 49 | $0.00 |
| 36591 | 0% | 32 | $0.00 | |
| 3074F | 0% | 102 | $0.00 | |
| 82962 | 0% | 12 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBREWER, DOUGLAS (CEO ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Tombigbee Healthcare Authority | Demopolis, AL | $1.30M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.